Cargando…
Safety, Tolerability, and Effect on Opioid Use of Meloxicam IV Following Orthopedic Surgery
OBJECTIVE: A Phase 3 randomized multicenter, double-blind, placebo-controlled trial (NCT02720692) compared once-daily intravenous (IV) meloxicam 30 mg to placebo, when added to the standard of care pain management regimens, in adults with moderate-to-severe pain following major elective surgery and...
Autores principales: | Sharpe, Kipling P, Berkowitz, Richard, Tyndall, William A, Boyer, David, McCallum, Stewart W, Mack, Randall J, Du, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982445/ https://www.ncbi.nlm.nih.gov/pubmed/32021411 http://dx.doi.org/10.2147/JPR.S216219 |
Ejemplares similares
-
Safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate to severe pain following laparoscopic abdominal surgery
por: Singla, Neil, et al.
Publicado: (2018) -
Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial
por: Berkowitz, Richard D, et al.
Publicado: (2021) -
A Phase 3, Randomized, Placebo‐Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery
por: Bergese, Sergio D., et al.
Publicado: (2019) -
Efficacy and Safety of Intravenous Meloxicam in Subjects with Moderate-to-severe Pain Following Abdominoplasty
por: Singla, Neil, et al.
Publicado: (2018) -
Analgesic Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-Severe Pain After Open Abdominal Hysterectomy: A Phase 2 Randomized Clinical Trial
por: Rechberger, Tomasz, et al.
Publicado: (2019)